Dr. Mark L Mahloch, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 South Pine, Valley, NE 68064 Phone: 402-359-2277 Fax: 402-359-5432 |
Dr. Cheryl R Macdonald, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 South Pine, Valley, NE 68064 Phone: 402-359-2277 Fax: 402-359-5432 |
Mr. Jared Pehrson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 S Pine St, Valley, NE 68064 Phone: 402-359-2277 Fax: 402-359-5432 |
Dr. Patrick J Mccarville, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 South Pine Street, Valley, NE 68064 Phone: 402-359-2277 Fax: 402-359-5432 |
Bernard C Hillyer, MD Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 51 Ginger Woods Rd, Valley, NE 68064 Phone: 402-639-6660 Fax: 402-359-2852 |
News Archive
Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don't get tested.
Prof. You-Me Kim and her student Dajung Jung at Pohang University of Science and Technology, in collaboration with Prof. Wonhwa Cho's group at the University of Illinois at Chicago, have identified that the majority of human Src homology 2 (SH2) domains not only bind to proteins, but also interact with membrane lipids with high affinity and specificity.
It was on a cold, sunny day in Baltimore last January that Curt Kwak, chief information officer of the Washington Health Benefit Exchange, first realized that the signature feature of President Obama's Affordable Care Act could be in trouble.
OriGene Technologies, Inc. today announced Royal Institute of Technology in Sweden has adopted its VERIFY Tagged Antigen(TM) (Over-expression Lysates) in the Human Protein Atlas program. This program is funded by the Knut and Alice Wallenberg Foundation and is set up to explore the human proteome systematically using Antibody-Based Proteomics.
A new portable device that utilizes artificial intelligence (AI) and biosensors can rapidly detect if cancer cells thrive after chemotherapy treatment.
› Verified 6 days ago